KP1077 Demonstrates Safety in Idiopathic Hypersomnia Patients
The phase 2 trial explored the safety and efficacy of KP1077 in reducing daytime sleepiness and sleep inertia.
Source: sleepreviewmag.com
Christopher Drake News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Christopher Drake. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Christopher Drake Today - Breaking & Trending Today
KP1077 Is Safe, Tolerable for Improving Idiopathic Hypersomnia Symptoms
A phase 2 trial found KP1077 provides clinically meaningful benefits for idiopathic hypersomnia.
Source: hcplive.com
Zevra Reports Positive Phase 2 Results for IH Drug Candidate
Zevra Therapeutics announced positive topline results from its phase 2 clinical trial evaluating KP1077 for idiopathic hypersomnia (IH).
Source: sleepreviewmag.com
Zevra Therapeutics Announces Top-Line Data from the Phase 2
KP1077 demonstrates clinically meaningful benefits for key IH symptoms Top-line data provide key information for the design of a Phase 3 study ...
Source: globenewswire.com
US states consider harsh 'war on drug'-era laws to combat fentanyl crisis | US news
Some lawmakers have even classified opioid as ‘weapon of terrorism’ and want impose the death sentence for its distribution
Source: theguardian.com